CN105124702B - 一种适用于经期女性的补充剂或饮料及其制备方法 - Google Patents
一种适用于经期女性的补充剂或饮料及其制备方法 Download PDFInfo
- Publication number
- CN105124702B CN105124702B CN201510606392.0A CN201510606392A CN105124702B CN 105124702 B CN105124702 B CN 105124702B CN 201510606392 A CN201510606392 A CN 201510606392A CN 105124702 B CN105124702 B CN 105124702B
- Authority
- CN
- China
- Prior art keywords
- calcium
- women
- beverage
- acid
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title description 19
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims abstract description 54
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 43
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000011575 calcium Substances 0.000 claims abstract description 42
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 42
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 30
- 239000000395 magnesium oxide Substances 0.000 claims abstract description 27
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 235000000346 sugar Nutrition 0.000 claims abstract description 26
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 25
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 25
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 25
- 235000019152 folic acid Nutrition 0.000 claims abstract description 23
- 239000011724 folic acid Substances 0.000 claims abstract description 23
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960000304 folic acid Drugs 0.000 claims abstract description 20
- 208000002173 dizziness Diseases 0.000 claims abstract description 18
- 230000003821 menstrual periods Effects 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 208000024891 symptom Diseases 0.000 claims abstract description 16
- 229960005069 calcium Drugs 0.000 claims description 41
- 239000000284 extract Substances 0.000 claims description 21
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 20
- 241000125175 Angelica Species 0.000 claims description 18
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 18
- 235000020710 ginseng extract Nutrition 0.000 claims description 17
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 16
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 15
- 239000004475 Arginine Substances 0.000 claims description 14
- 239000000787 lecithin Substances 0.000 claims description 12
- 235000010445 lecithin Nutrition 0.000 claims description 12
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 11
- 229940067606 lecithin Drugs 0.000 claims description 11
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 10
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 10
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 7
- 235000008434 ginseng Nutrition 0.000 claims description 7
- 206010025482 malaise Diseases 0.000 claims description 7
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 5
- 239000001527 calcium lactate Substances 0.000 claims description 5
- 235000011086 calcium lactate Nutrition 0.000 claims description 5
- 229960002401 calcium lactate Drugs 0.000 claims description 5
- 235000015872 dietary supplement Nutrition 0.000 claims description 5
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 4
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 claims description 4
- 235000002710 Ilex cornuta Nutrition 0.000 claims description 4
- 241001310146 Ilex cornuta Species 0.000 claims description 4
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims description 4
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 claims description 4
- CHBZUZOXEZJCOS-UHFFFAOYSA-N [Ca].N.P(O)(O)(O)=O Chemical compound [Ca].N.P(O)(O)(O)=O CHBZUZOXEZJCOS-UHFFFAOYSA-N 0.000 claims description 4
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 4
- 229940114124 ferulic acid Drugs 0.000 claims description 4
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 4
- 235000001785 ferulic acid Nutrition 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 229940089161 ginsenoside Drugs 0.000 claims description 4
- 229930182494 ginsenoside Natural products 0.000 claims description 4
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 4
- 229940014144 folate Drugs 0.000 claims description 3
- LVBRFZFUCKKGDJ-HJWRJIQTSA-J magnesium;dipotassium;(2s)-2-aminobutanedioate;hydron Chemical compound [Mg+2].[K+].[K+].OC(=O)[C@@H](N)CC([O-])=O.OC(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC(O)=O.[O-]C(=O)[C@@H](N)CC(O)=O LVBRFZFUCKKGDJ-HJWRJIQTSA-J 0.000 claims description 3
- 229940111263 potassium magnesium aspartate Drugs 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- 241000213006 Angelica dahurica Species 0.000 claims description 2
- 235000001465 calcium Nutrition 0.000 abstract description 31
- 238000000034 method Methods 0.000 abstract description 11
- 208000001953 Hypotension Diseases 0.000 abstract description 8
- 208000012866 low blood pressure Diseases 0.000 abstract description 8
- 239000013589 supplement Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 235000009697 arginine Nutrition 0.000 description 13
- 229960003121 arginine Drugs 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007938 effervescent tablet Substances 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 229940091250 magnesium supplement Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 229910001425 magnesium ion Inorganic materials 0.000 description 3
- 229960003390 magnesium sulfate Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- SMHNUIFHMAGAFL-UHFFFAOYSA-N calcium;2-hydroxypropanoic acid Chemical compound [Ca].CC(O)C(O)=O SMHNUIFHMAGAFL-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 229940036630 folic acid 0.2 mg Drugs 0.000 description 2
- 229940083626 folic acid 0.4 mg Drugs 0.000 description 2
- 229940083563 folic acid 1 mg Drugs 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000004530 Echinacea purpurea Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 244000104547 Ziziphus oenoplia Species 0.000 description 1
- KCIVQLGSJLQRDA-ILKKLZGPSA-N [Mg].[K].C(CC)N[C@@H](CCO)C(=O)O Chemical compound [Mg].[K].C(CC)N[C@@H](CCO)C(=O)O KCIVQLGSJLQRDA-ILKKLZGPSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940051497 arginine 1000 mg Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940085912 calcium carbonate 200 mg Drugs 0.000 description 1
- 229940085869 calcium carbonate 300 mg Drugs 0.000 description 1
- 229940085862 calcium carbonate 500 mg Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical group [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940110377 dl- arginine Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000002011 intestinal secretion Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- HHCCNQLNWSZWDH-UHFFFAOYSA-N n-hydroxymethanimine oxide Chemical compound O[N+]([O-])=C HHCCNQLNWSZWDH-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 230000002746 orthostatic effect Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 229940067626 phosphatidylinositols Drugs 0.000 description 1
- CCTIOCVIZPCTGO-BYPYZUCNSA-N phosphoarginine Chemical class OC(=O)[C@@H](N)CCCNC(=N)NP(O)(O)=O CCTIOCVIZPCTGO-BYPYZUCNSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明提供了一种适用于女性的饮料和补充剂,包括:维生素B12、叶酸、钙剂、镁剂、红糖和水。所述的适用于女性的饮料和补充剂能有效缓解女性在经期出现的头晕、脸色苍白、虚弱、低体位、低血压等症状,比传统补充红糖水的方法效果更显著,特别是对于经期女性头晕症状的缓解起效更快、效果更佳。
Description
技术领域
本发明涉及一种补充剂或饮料及其制备方法,具体涉及一种适用于经期女性的补充剂或饮料及其制备方法。
背景技术
女性在月经前期和月经期间都会出现头晕眼花、脸色苍白、虚弱、低体位、低血压等症状。特别是头晕,其成因可能与出血多、贫血、精神紧张造成的植物神经紊乱、体位性低血压均有相关性,稍微严重者还会出现晕倒、周身虚弱无力甚至不能行动等严重症状,对于经期女性存在严重的影响。传统方法一般都是补充红糖水的方法来增加人体热量和提高人体系统免疫力,这种方法在一定程度上虽能缓解经期的各种症状,但起效慢并且效果不佳。
CN1232699A公开了一种防治女子月经病症的保健饮料,由当归、白芍、香附、阿胶、甘草等十五味中药及胡罗卜汁、蜂蜜等配制而成,具有免疫调节,补血调血、行气活血的功能。然而,该饮料成分复杂,制备方法繁琐,并且由于存在多种中药成分,口感不佳。
CN101703250A公开了一种营养补充食品用于孕期女性的饮食补充配方:蛋白质粉20g、钙镁片9片、天然B族维生素6片、复合维生素C3片、铁质叶酸片6片、类胡萝卜素3粒、小麦胚油胶囊6粒、松果菊片6片。该配方需要患者每天服用大量补充剂,给患者带来负担,并且其活性成分含量不适用于经期女性。
CN103461872A公开一种孕妇保健叶酸口服液,由下述重量份的原料制成:红糖30-50份、龙眼肉5-10份、当归5-10份、干红枣5-10份、叶酸2-5份、蜂蜜5-10份。该口服液适用于对女性补血功能,然而难以缓解经期女性的其他症状。
因此,为克服现有技术的缺陷,本发明提供了一种适用于经期女性的补充剂或饮料及其制备方法。
发明内容
本发明一个目的是提供一种补充剂或女性饮料,用于缓解或减轻女性在经期前、月经期间和月经后出现的头晕、脸色苍白、虚弱、低体位、低血压等症状。
本发明另一个目的是解决现有补充剂或女性饮料对于经期女性头晕症状的缓解起效慢、效果不佳的问题。
本发明的还一个目的是提供一种适用于经期女性的补充剂或女性饮料的制备方法,解决了现有补充剂或女性饮料制备工艺复杂,成本较高的缺陷。
本发明首先提供了一种适用于女性饮用的饮料,包括:维生素B12、叶酸、钙剂、镁剂、红糖和水。
维生素B12又叫钴胺素,是唯一含金属元素的维生素。自然界中的维生素B12都是微生物合成的,高等动植物不能制造维生素B12。维生素B12是惟一的一种需要肠道分泌物帮助才能被吸收的维生素。现有研究表明,维生素B12可以提高叶酸利用率、维护神经髓鞘的代谢与功能、促进红细胞的发育和成熟、参与脱氧核酸的合成,脂肪、碳水化合物及蛋白质的代谢,增加核酸与蛋白质的合成。在本发明的饮料中每100ml饮料中所述的维生素B12含量为30-100mg,优选的,含量为30-60mg,更优选的,含量为50mg。
叶酸是人体在利用糖分和氨基酸时的必要物质,是机体细胞生长和繁殖所必需的物质。叶酸帮助蛋白质的代谢,并与维生素B12共同促进红细胞的生成和成熟,是制造红血球不可缺少的物质。人体缺少叶酸可导致红血球的异常,未成熟细胞的增加,贫血以及白血球减少。在本发明的饮料中每100ml饮料中所述的叶酸含量为0.2-1mg,优选的,含量为0.3-0.6mg,更优选的,含量为0.4mg。
钙主要用于形成和维持骨骼、牙齿的结构,并可维持细胞的正常生理状态,细胞内的钙离子是细胞对刺激产生反应的媒介,并参与血液凝固过程。钙对人体的重要作用是不可替代的,处于经期的女性通常缺钙现象比较突出,临床表现为四肢无力、经常抽筋、麻木、腰酸背疼、关节疼、风湿疼、头晕等。在本发明中,所述的钙剂选自碳酸钙,磷酸氨钙、乳酸钙,枸缘酸钙,活性钙,有机钙等。优选的,所述的钙剂选自碳酸钙,乳酸钙,更优选的,所述的钙剂选自碳酸钙。本发明中的饮料中每100ml饮料中所述的钙剂含量为50-500mg,优选的,含量为100-400mg,更优选的,含量为300mg。
镁对神经、肌肉的传递及活动有重要影响。镁与钙之间有时为协调作用,有时则呈现拮抗作用。任何需要三磷酸腺苷参加的反应都需要镁离子,所以镁离子是糖代谢及细胞呼吸酶系统不可缺少的辅助因子。由于镁离子形成有关,脂代谢也需要镁离子。临床上,镁可用于治疗缺血性心脏病时维持心脏的正常节律。在本发明中,所述的镁剂选自硫酸镁、门冬氨酸钾镁、氧化镁,优选的,所述的镁剂选自硫酸镁。本发明中的饮料中每100ml饮料中所述的镁剂含量为100-300mg,优选的,含量为120-200mg,更优选的,含量为160mg。
红糖指带蜜的甘蔗成品糖,甘蔗经榨汁,浓缩形成的带蜜糖。红糖按结晶颗粒不同,分为赤砂糖、红糖粉、碗糖等。红糖可加速皮肤细胞的代谢,为细胞提供能量,可加速血液循环、增加血容量的成分,刺激机体的造血功能,并能抵抗自由基,重建和保护细胞基础结构,维护细胞的正常功能和新陈代谢。本发明中的饮料中每100ml饮料中所述的红糖含量为1-20g,优选的,含量为5-15g,更优选的,含量为10g。
在本发明的一个实施方式中,本发明所述的适用于女性的饮料中,每100ml饮料中包括如下重量的成分:维生素B12 30-100mg、叶酸0.2-1mg、钙剂50-500mg、镁剂100-300mg、红糖1-20g。
在本发明的一个实施方式中,本发明所述的适用于女性的饮料中,每100ml饮料中由如下重量的成分组成:维生素B12 30-100mg、叶酸0.2-1mg、钙剂50-500mg、镁剂100-300mg、红糖1-20g,余量为水。
优选的,本发明所述的适用于女性的饮料的组成成分中还含有精氨酸。精氮酸作为人体代谢生物因子的载体,能诱导、刺激肾上腺素的生成,缓和降低血糖和减少脂肪酸的生成,并能够增强人体的免疫力、延缓衰老:能防止胸腺退化,补充精氨酸能增加胸腺的能量,促进胸腺中淋巴细胞CD细胞增长。
本发明所述的精氨酸可以是L-精氨酸、D-精氨酸、作为消旋体的DL-精氨酸中的任意一种,优选的,所述的精氨酸选自L-精氨酸。另外,作为精氨酸,可以使用游离的精氨酸和/或精氨酸的盐。作为精氨酸的盐,可以选自精氨酸盐酸盐、精氨酸磷酸盐、精氨酸谷氨酸盐。本发明所述的饮料中每100ml饮料中含有精氨酸为0.001-5g,优选的,含量为0.1-4.5g,更优选的,含量为1-2g。
优选的,本发明所述的适用于女性的饮料的组成成分中还含有卵磷脂。卵磷脂是大豆和蛋黄中提取的一种自然甘油酯,其构成成分包括磷酸、胆碱、脂肪酸、甘油、糖脂、甘油三酸酯以及磷脂(如磷脂酰胆碱、磷脂酰乙醇胺和磷脂酰肌醇)。卵磷脂是生命的基本物质,是人体细胞的根基组成因素。本发明所述的饮料中每100ml饮料中含有卵磷脂为0.1-10g,优选的,含量为0.5-5g,更优选的,含量为1-2g。
优选的,本发明所述的适用于女性的饮料的组成成分中还含有当归提取物和/或人参提取物。
当归具有补血活血的作用,其成分有双向性,它含有兴奋和抑制子宫平滑肌的两种成分。当归提取物制备方法可以采用本领域常规的提取方法,例如回流提取法、溶剂浸提法、分子蒸馏法等,具体制备方法可以参考专利CN102266104A、CN103461872A等中公开内容。在本发明一个具体实施方式中,所述的当归提取物为挥发油,其制备方法为:当归粉碎,过目5-10筛,与水按重量比为1∶10的比例侵泡8-10h,然后水蒸气蒸馏3-10h,静置冷却,得当归挥发油。在本发明的另一个实施方式中,本发明所述的当归提取物种按质量百分比含有至少1%蒿本内酯和0.1%阿魏酸。本发明的饮料中每100ml饮料中含有所述的当归提取物0.1-1g,优选的,含有所述的当归提取物0.2-0.6g,更优选的,含有所述的当归提取物0.2-0.4g。
人参具有多种生理活性,现代医学认为人参能保护机体细胞和全身免受精神和身体应激的影响,能增强智力,延缓疲劳,提高工作能力,并能使增设的血糖和血胆固醇降低,促进新陈代谢等。人参提取物制备方法可以采用本领域常规的提取方法,例如回流提取法、溶剂浸提法、分子蒸馏法等,具体制备方法可以参考专利CN102356895A、CN101180323A等中公开内容。在本发明一个实施方式中,所述的人参提取物制备方法为将人参粉碎,加入体积浓度为50-70%的乙醇浸泡1-5小时,乙醇的加入量是干燥后的人参重量的4-10倍,回流提取1-3小时,过滤后,滤渣加滤渣重量的4-8倍量50-70%乙醇回流提取1-3小时,过滤,合并提取液,减压浓缩,浓缩至在60℃时相对密度1.20~1.30的清膏,得到人参提取物。在本发明的一个实施方式中,本发明所述的人参提取物中按质量比含有人参总皂苷至少10%。本发明的饮料中每100ml饮料中含有所述的人参提取物0.1-1g,优选的,含有所述的人参提取物0.2-0.6g,更优选的,含有所述的人参提取物0.2-0.4g。
在本发明的一个实施方式中,本发明所述的适用于女性的饮料中,每100ml饮料中包括如下重量的成分:维生素B12 30-100mg、叶酸0.2-1mg、钙剂50-500mg、镁剂100-300mg、精氨酸0.001-5g、卵磷脂0.1-10g、当归提取物0.1-1g、人参提取物0.1-1g、红糖1-20g。
在本发明的一个实施方式中,本发明所述的适用于女性的饮料中,每100ml饮料中由如下重量的成分组成:维生素B12 30-100mg、叶酸0.2-1mg、钙剂50-500mg、镁剂100-300mg、精氨酸0.001-5g、卵磷脂0.1-10g、当归提取物0.1-1g、人参提取物0.1-1g、红糖1-20g,余量为水。
在本发明的一个具体实施方式中,本发明所述的适用于女性的饮料中还可以含有常用的添加剂,所述的添加剂选自pH调节剂(例如柠檬酸钠)、稳定剂(例如糊精、胶质等)、酸度调味剂(例如柠檬酸)、防腐剂(例如山梨酸钾)、色素(例如柠檬黄)等。本发明所述的饮料的每100ml饮料中pH调节剂含量为0.02~0.1g、稳定剂含量为0.1~0.5g、酸度调味剂含量为0.02~0.1g、防腐剂含量为0.01~0.05g、色素含量为0.001-0.01g。
本发明的还一方面提供了一种适用于女性的补充剂,所述的补充剂包括维生素B1230-100mg、叶酸0.2-1mg、钙剂50-500mg、镁剂100-300mg。
本发明的还一方面提供了一种适用于女性的补充剂,所述的补充剂由维生素B1230-100mg、叶酸0.2-1mg、钙剂50-500mg、镁剂100-300mg组成。
优选的,所述的维生素B12含量为30-60mg,更优选的,含量为50mg。优选的,所述的叶酸含量为0.3-0.6mg,更优选的,含量为0.4mg。所述的钙剂选自碳酸钙,磷酸氨钙、乳酸钙,枸缘酸钙,活性钙,有机钙中的一种或两种以上的组合,优选的,所述的钙剂选自碳酸钙,乳酸钙,更优选的,所述的钙剂选自碳酸钙,本发明中,所述的钙剂优选的含量为100-400mg,更优选的,含量为300mg。所述的镁剂选自硫酸镁、门冬氨酸钾镁、氧化镁,优选的,所述的镁剂选自硫酸镁。所述的镁剂优选的,含量为120-200mg,更优选的,含量为160mg。
优选的,本发明所述的适用于女性的补充剂中还含有1-500mg精氨酸,更优选的,还含有10-200mg精氨酸。优选的,本发明所述的适用于女性的补充剂中还含有1-500mg卵磷脂,更优选的,还含有10-200mg卵磷脂。优选的,本发明所述的适用于女性的补充剂中还含有1-500mg当归提取物,更优选的,还含有10-200mg当归提取物。优选的,本发明所述的适用于女性的女性补充剂中还含有1-500mg人参提取物,更优选的,还含有10-200mg人参提取物。
本发明所述的适用于女性的补充剂可以为片剂、胶囊剂、散剂、颗粒剂、膜剂等。优选的,本发明所述的适用于女性的补充剂可以为泡腾片剂。在本发明的一个实施方式中,本发明所述的适用于女性的补充剂为泡腾片剂,其中包括酸源、碱源、润滑剂、填充剂、黏合剂、发泡剂。更优选的,本发明所述的适用于女性的补充剂中还包括矫味剂、甜味剂、香精、色素。其中,所述的补充剂中含有按质量比酸源10-40%、碱源10-40%、润滑剂1-10%、填充剂1-20%、黏合剂1-10%、发泡剂0.1-5%、矫味剂0.1-5%、甜味剂0.1-5%、香精0.1-5%、色素0.1-5%。所述的酸源选自柠檬酸、酒石酸、富马酸、己二酸、苹果酸中的一种或两种以上。所述的碱源选自碳酸钠、碳酸氢钠、碳酸钾、碳酸氢钾、碳酸钙中的一种或两种以上。
本发明还提供了一种所述的适用于女性的补充剂在制备预防和/或治疗经期不适症状的食品和/或膳食补充剂中的应用。所述的经期不适症状选自头晕、脸色苍白、虚弱、低体位、低血压,优选的,所述的经期不适症状选自头晕。
本发明的另一方面还公开了一种适用于女性的饮料的制备方法,包括如下步骤:按比例称取维生素B12、叶酸、钙剂、镁剂、红糖,加入水混合调配,杀菌消毒,后装瓶。
在本发明的一个具体实施方式中,所述的适用于女性的饮料的制备方法包括:制备当归提取物、人参提取物,按比例称取当归提取物、人参提取物、维生素B12、叶酸、钙剂、镁剂、精氨酸、卵磷脂、红糖,加入水混合调配,杀菌消毒,后装瓶。
本发明还提供了一种所述的适用于女性的饮料在制备预防和/或治疗经期不适症状的食品和/或膳食补充剂中的应用。所述的经期不适症状选自头晕、脸色苍白、虚弱、低体位、低血压,优选的,所述的经期不适症状选自头晕。
本发明所述的适用于女性的饮料能有效缓解女性在经期出现的头晕、脸色苍白、虚弱、低体位、低血压等症状,比传统补充红糖水的方法效果更显著,特别是对于经期女性头晕症状的缓解起效更快、效果更佳。
具体实施方式
下面结合实施例对本发明作进一步描述,但这些实施例不应被理解为对本发明保护范围的限制。
实施例1适用于女性的饮料制备:
按每100ml饮料中含维生素B12 50mg、叶酸0.4mg、碳酸钙300mg、硫酸镁160mg、红糖5g的比例称取上述组分,将以上组分加水调配,后按计量装瓶,再次杀菌消毒后制成。
实施例2适用于女性的饮料制备:
按每100ml饮料中含维生素B12 100mg、叶酸0.2mg、乳酸钙120mg、硫酸镁200mg、红糖20g的比例称取上述组分,将以上组分加水调配,后按计量装瓶,再次杀菌消毒后制成。
实施例3适用于女性的饮料制备:
取市售获得的当归提取物(按质量百分比含有蒿本内酯>1%和阿魏酸>0.1%)和市售获得的人参提取物(按质量比含有人参总皂苷>10%),按每100ml饮料中含维生素B12 30mg、叶酸1mg、碳酸钙500mg、硫酸镁300mg、红糖2g、精氨酸2000mg、卵磷脂2000mg、当归提取物200mg、人参提取物400mg的比例称取上述组分,将以上组分加水调配,后按计量装瓶,再次杀菌消毒后制成。
实施例4适用于女性的饮料制备:
取市售获得的当归提取物(按质量百分比含有蒿本内酯>1%和阿魏酸>0.1%)和市售获得的人参提取物(按质量比含有人参总皂苷>10%),按每100ml饮料中含维生素B12 80mg、叶酸0.4mg、碳酸钙200mg、硫酸镁200mg、精氨酸1000mg、卵磷脂1000mg、红糖10g、当归提取物400mg、人参提取物200mg的比例称取上述组分,将以上组分加水调配,后按计量装瓶,再次杀菌消毒后制成。
实施例5适用于女性的补充剂(泡腾片)
维生素B12 30mg
叶酸1mg
钙剂500mg
镁剂100mg
辅料:碳酸氢钠、微晶纤维素、乳糖、富马酸、羟丙甲纤维素、聚丙烯酸树酯、十六醇、吐温-80、硬酯酸镁。
制备工艺:将羟丙甲纤维素溶于60%乙醇中,丙烯酸树酯溶于85%乙醇中,二者按1∶1混合,将十六醇加热熔融后加入到上述混合液中,随加随搅拌,最后加吐温-80制成黏合剂;取维生素B12、叶酸、钙剂、镁剂、碳酸氢钠、微晶纤维素、乳糖,粉碎、过筛、混合,加混合黏合剂制粒,干燥,整粒,制成碱颗粒;取富马酸粉碎,过筛,加混合黏合剂制粒,干燥,整粒,制成酸颗粒;取酸碱颗粒按比例混匀,加硬酯酸镁压片。
实施例6适用于女性的补充剂(泡腾片)
维生素B12 100mg
叶酸0.2mg
钙剂50mg
镁剂300mg
辅料及制备工艺同实施例5。
实施例7本发明适用于女性饮料对经期不适症状的改善效果
安排30位经期表现为头晕症状的女性志愿者,将30位志愿者平均分成A、B、C三组,每组10人,A组在经期饮用按实施例1制备的饮料或服用按照实施5制备的泡腾片,B组在经期饮用红糖水,C组在经期饮用饮用水,观察头晕时间,其结果如下表所示:
由上述结果可见,本发明所述的适用于女性的饮料或补充剂能够有效缓解女性在经期出现的头晕、脸色苍白、虚弱、低体位、低血压等症状,比传统补充红糖水的方法效果更显著,特别是对于经期女性头晕症状的缓解起效更快。
上述实施例不以任何方式限制本发明,凡是采用等同替换或等效变换的方式获得的技术方案均落在本发明的保护范围内。
Claims (5)
1.一种适用于女性的饮料,其特征在于,每100ml饮料中由如下重量的成分组成:维生素B12 30-60mg、叶酸0.3-0.6mg、钙剂100-400mg、镁剂120-200mg、红糖1-20g,余量为水,所述的钙剂选自碳酸钙,磷酸氨钙、乳酸钙,枸缘酸钙,活性钙,有机钙中的一种或两种以上的组合,所述的镁剂选自硫酸镁、门冬氨酸钾镁、氧化镁中的一种或两种以上的组合。
2.权利要求1所述的适用于女性的饮料,其特征在于,所述的维生素B12含量为50mg;所述的叶酸含量为0.4mg;所述的钙剂含量为300mg;所述的镁剂含量为160mg。
3.一种适用于女性的饮料,其特征在于,每100ml饮料中由如下重量的成分组成:维生素B12 30-60mg、叶酸0.3-0.6mg、钙剂100-400mg、镁剂120-200mg、红糖1-20g、精氨酸0.001-5g、卵磷脂0.1-10g、当归提取物0.2-0.6g和/或人参提取物0.2-0.6g,余量为水,所述的钙剂选自碳酸钙,磷酸氨钙、乳酸钙,枸缘酸钙,活性钙,有机钙中的一种或两种以上的组合,所述的镁剂选自硫酸镁、门冬氨酸钾镁、氧化镁中的一种或两种以上的组合。
4.权利要求3所述的适用于女性的饮料,其特征在于,所述的当归提取物中按质量百分比含有至少1%蒿本内酯和0.1%阿魏酸或者所述的当归提取物为当归挥发油;所述的人参提取物中按质量比含有人参总皂苷至少10%。
5.权利要求1-4任意一项所述的适用于女性的饮料在制备用于经期不适症状的食品和/或膳食补充剂中的应用,所述的经期不适症状选自头晕。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510606392.0A CN105124702B (zh) | 2015-09-22 | 2015-09-22 | 一种适用于经期女性的补充剂或饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510606392.0A CN105124702B (zh) | 2015-09-22 | 2015-09-22 | 一种适用于经期女性的补充剂或饮料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105124702A CN105124702A (zh) | 2015-12-09 |
CN105124702B true CN105124702B (zh) | 2018-09-11 |
Family
ID=54710576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510606392.0A Active CN105124702B (zh) | 2015-09-22 | 2015-09-22 | 一种适用于经期女性的补充剂或饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105124702B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230041289A1 (en) * | 2021-08-05 | 2023-02-09 | Innovus Pharmaceuticals, Inc. | Compositions and methods for enhancing or treating female sexual response |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0184226B1 (ko) * | 1996-06-18 | 1999-03-20 | 안용찬 | 멜라토닌을 함유한 기능성 음료 |
US20060024409A1 (en) * | 2004-07-29 | 2006-02-02 | Everett Laboratories, Inc. | Compositions and methods for nutrition supplementation |
CN101779809A (zh) * | 2009-01-21 | 2010-07-21 | 陈石良 | 女性经期专用固体保健饮料及其制备方法 |
CN103815227A (zh) * | 2014-03-14 | 2014-05-28 | 王俊平 | 一种复合维生素红糖组合物及其应用 |
CN103989044A (zh) * | 2014-05-30 | 2014-08-20 | 王俊平 | 一种配方红糖组合物及其应用 |
-
2015
- 2015-09-22 CN CN201510606392.0A patent/CN105124702B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105124702A (zh) | 2015-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103784611B (zh) | 一种具有改善睡眠帮助缓解压力的组合物及其应用 | |
CN103054044B (zh) | 一种改善睡眠的保健食品组合物 | |
WO2018077312A1 (zh) | 一种增强免疫力的泡腾片及其制备方法 | |
CN102397525B (zh) | 一种具有改善营养性贫血功能的中药组合物及其制备方法 | |
CN107455625A (zh) | 一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺 | |
CN109090603A (zh) | 一种酸枣百合膏的配方及其制备方法 | |
CN102188610A (zh) | 一种具有改善睡眠功能的中药组合物及其制备方法 | |
CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
CN102048884A (zh) | 一种含瓜拉那提取物的减肥组合物 | |
CN109077306A (zh) | 一种缓解疲劳的组合物及其制备方法 | |
CN103750464A (zh) | 一种山菇益智功能饮料及其制备方法 | |
CN109528904A (zh) | 一种补肾强身、补气养阴、高含量人参皂苷的药物组合物及其制备方法 | |
CN105920198B (zh) | 一种具有补血功效的细胞破壁微粉及其制备方法 | |
CN105124702B (zh) | 一种适用于经期女性的补充剂或饮料及其制备方法 | |
CN104783033A (zh) | 一种牡蛎深加工复合功能食品 | |
CN102258628B (zh) | 一种具有促进排铅作用的中药组合物 | |
CN103773659B (zh) | 补酒及制作方法 | |
CN102600303A (zh) | 以刺五加和西洋参为基础的抗疲劳组合物及其制备方法 | |
CN103005439B (zh) | 一种苦瓜复方降脂口服液及其制备方法 | |
CN102028230A (zh) | 一种保健品辅料及其应用 | |
CN109090319A (zh) | 乳矿物盐压片糖果 | |
CN101574509A (zh) | 容颜不老制剂 | |
CN101474304A (zh) | 用于降低血糖与血脂的药物组合物 | |
CN1985850B (zh) | 一种用于口服补充钙镁铁的药物组合物及制备方法和用途 | |
CN103110675A (zh) | 改善营养性贫血软胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: Wang Shufang Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190423 Address after: 100080 Beijing Haidian District, Sijiqing Road, No. 7 Courtyard 1 Building-1 to 3 Floors 102, east of 3 Floors E62 Patentee after: Beijing Ruikang Technology Co., Ltd. Address before: 100040 Xucheng 3-2106, Shijingshan District, Beijing Patentee before: Wang Shufang |
|
TR01 | Transfer of patent right |